Therapeutic trials in multiple sclerosis.
Several recently completed clinical trials are reported to demonstrate beneficial treatment with immunosuppressive therapy in multiple sclerosis (MS). The enthusiasm generated by these reports may motivate investigators to further such trials even in the face of the appreciable expense, time and ris...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1984
|
| _version_ | 1797065467778564096 |
|---|---|
| author | Noseworthy, J Seland, T Ebers, G |
| author_facet | Noseworthy, J Seland, T Ebers, G |
| author_sort | Noseworthy, J |
| collection | OXFORD |
| description | Several recently completed clinical trials are reported to demonstrate beneficial treatment with immunosuppressive therapy in multiple sclerosis (MS). The enthusiasm generated by these reports may motivate investigators to further such trials even in the face of the appreciable expense, time and risk involved. Of at least equal concern, clinicians are proceeding to treat individual MS patients without adequate evaluation of the claims. Critical appraisals of available data and proposals for future therapeutic endeavors therefore seem in order and are made in this paper. |
| first_indexed | 2024-03-06T21:29:05Z |
| format | Journal article |
| id | oxford-uuid:440d8321-eefe-415e-a2bc-d980f9a5227c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:29:05Z |
| publishDate | 1984 |
| record_format | dspace |
| spelling | oxford-uuid:440d8321-eefe-415e-a2bc-d980f9a5227c2022-03-26T14:59:17ZTherapeutic trials in multiple sclerosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:440d8321-eefe-415e-a2bc-d980f9a5227cEnglishSymplectic Elements at Oxford1984Noseworthy, JSeland, TEbers, GSeveral recently completed clinical trials are reported to demonstrate beneficial treatment with immunosuppressive therapy in multiple sclerosis (MS). The enthusiasm generated by these reports may motivate investigators to further such trials even in the face of the appreciable expense, time and risk involved. Of at least equal concern, clinicians are proceeding to treat individual MS patients without adequate evaluation of the claims. Critical appraisals of available data and proposals for future therapeutic endeavors therefore seem in order and are made in this paper. |
| spellingShingle | Noseworthy, J Seland, T Ebers, G Therapeutic trials in multiple sclerosis. |
| title | Therapeutic trials in multiple sclerosis. |
| title_full | Therapeutic trials in multiple sclerosis. |
| title_fullStr | Therapeutic trials in multiple sclerosis. |
| title_full_unstemmed | Therapeutic trials in multiple sclerosis. |
| title_short | Therapeutic trials in multiple sclerosis. |
| title_sort | therapeutic trials in multiple sclerosis |
| work_keys_str_mv | AT noseworthyj therapeutictrialsinmultiplesclerosis AT selandt therapeutictrialsinmultiplesclerosis AT ebersg therapeutictrialsinmultiplesclerosis |